Healthcare provider profile · identity verified

William Rippe, M.D.

Internal Medicine · SAINT JOSEPH, MO · NPI 1710070586

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	520	125
Atorvastatin Calcium	Atorvastatin Calcium	375	98
Omeprazole	Omeprazole	297	71
Lisinopril	Lisinopril	293	78
Potassium Chloride	Potassium Chloride	264	60
Amlodipine Besylate	Amlodipine Besylate	252	66
Furosemide	Furosemide	252	71
Tramadol Hcl	Tramadol Hcl	249	87
Levothyroxine Sodium	Levothyroxine Sodium	240	58
Clonazepam	Clonazepam	231	56
Metoprolol Succinate	Metoprolol Succinate	195	46
Hydrochlorothiazide	Hydrochlorothiazide	188	52
Gabapentin	Gabapentin	175	45
Alprazolam	Alprazolam	169	44
Prednisone	Prednisone	127	37
Pantoprazole Sodium	Pantoprazole Sodium	120	35
Tamsulosin Hcl	Tamsulosin Hcl	117	31
Pregabalin	Pregabalin	115	34
Sertraline Hcl	Sertraline Hcl	115	24
Rosuvastatin Calcium	Rosuvastatin Calcium	112	28
Simvastatin	Simvastatin	108	27
Metoprolol Tartrate	Metoprolol Tartrate	101	29
Losartan Potassium	Losartan Potassium	93	24
Escitalopram Oxalate	Escitalopram Oxalate	92	27
Metformin Hcl	Metformin Hcl	91	27
Donepezil Hcl	Donepezil Hcl	87	15
Carvedilol	Carvedilol	86	22
Lorazepam	Lorazepam	86	38
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	83	22
Oxycodone Hcl	Oxycodone Hcl	80	35
Methylprednisolone	Methylprednisolone	75	61
Clopidogrel	Clopidogrel Bisulfate	74	19
Duloxetine Hcl	Duloxetine Hcl	73	13
Azithromycin	Azithromycin	71	54
Meloxicam	Meloxicam	71	18
Fluticasone Propionate	Fluticasone Propionate	70	32
Metolazone	Metolazone	69	14
Hydromorphone Hcl	Hydromorphone Hcl	65	suppressed
Doxycycline Hyclate	Doxycycline Hyclate	62	34
Amitriptyline Hcl	Amitriptyline Hcl	59	11
Allopurinol	Allopurinol	57	12
Quetiapine Fumarate	Quetiapine Fumarate	55	11
Temazepam	Temazepam	55	12
Paroxetine Hcl	Paroxetine Hcl	48	suppressed
Jardiance	Empagliflozin	46	13
Ezetimibe	Ezetimibe	44	suppressed
Warfarin Sodium	Warfarin Sodium	44	suppressed
Alendronate Sodium	Alendronate Sodium	42	suppressed
Amiodarone Hcl	Amiodarone Hcl	42	suppressed
Citalopram Hbr	Citalopram Hydrobromide	42	suppressed
Eliquis	Apixaban	42	suppressed
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	42	12
Mirtazapine	Mirtazapine	37	suppressed
Estradiol	Estradiol	36	suppressed
Farxiga	Dapagliflozin Propanediol	36	suppressed
Torsemide	Torsemide	35	suppressed
Ciprofloxacin Hcl	Ciprofloxacin Hcl	34	29
Finasteride	Finasteride	34	suppressed
Ozempic	Semaglutide	34	suppressed
Diclofenac Sodium	Diclofenac Sodium	33	suppressed
Esomeprazole Magnesium	Esomeprazole Magnesium	33	suppressed
Sulfamethoxazole-Trimethoprim	Sulfamethoxazole/Trimethoprim	32	28
Trazodone Hcl	Trazodone Hcl	32	14
Fentanyl	Fentanyl	31	suppressed
Ondansetron Hcl	Ondansetron Hcl	29	16
Triamcinolone Acetonide	Triamcinolone Acetonide	29	15
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	28	12
Buspirone Hcl	Buspirone Hcl	27	suppressed
Morphine Sulfate Er	Morphine Sulfate	27	suppressed
Cephalexin	Cephalexin	26	20
Spironolactone	Spironolactone	26	12
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	25	23
Oxybutynin Chloride	Oxybutynin Chloride	25	suppressed
Diltiazem Hcl	Diltiazem Hcl	24	suppressed
Fluconazole	Fluconazole	24	21
Zolpidem Tartrate	Zolpidem Tartrate	24	12
Fluoxetine Hcl	Fluoxetine Hcl	23	suppressed
Glipizide	Glipizide	23	suppressed
Pramipexole Dihydrochloride	Pramipexole Di-Hcl	23	suppressed
Primidone	Primidone	23	suppressed
Albuterol Sulfate Hfa	Albuterol Sulfate	22	16
Celecoxib	Celecoxib	22	suppressed
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	22	suppressed
Synthroid	Levothyroxine Sodium	22	suppressed
Diphenoxylate-Atropine	Diphenoxylate Hcl/Atropine	21	suppressed
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	21	suppressed
Levetiracetam	Levetiracetam	21	suppressed
Levofloxacin	Levofloxacin	21	19
Ramipril	Ramipril	21	suppressed
Fenofibrate	Fenofibrate	20	suppressed
Lovastatin	Lovastatin	20	suppressed
Methimazole	Methimazole	20	suppressed
Montelukast Sodium	Montelukast Sodium	20	suppressed
Testosterone Cypionate	Testosterone Cypionate	20	suppressed
Valsartan	Valsartan	20	suppressed
Nifedipine Er	Nifedipine	19	suppressed
Haloperidol	Haloperidol	17	suppressed
Latanoprost	Latanoprost	17	suppressed
Nitrofurantoin	Nitrofurantoin Macrocrystal	17	suppressed
Pravastatin Sodium	Pravastatin Sodium	17	suppressed
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	17	suppressed
Midodrine Hcl	Midodrine Hcl	16	suppressed
Spiriva Handihaler	Tiotropium Bromide	16	suppressed
Betamethasone Dipropionate	Betamethasone Dipropionate	15	suppressed
Carbidopa-Levodopa	Carbidopa/Levodopa	15	suppressed
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	15	suppressed
Famotidine	Famotidine	15	suppressed
Incruse Ellipta	Umeclidinium Bromide	15	suppressed
Techlite Pen Needle	Pen Needle, Diabetic	15	suppressed
Linzess	Linaclotide	14	suppressed
Paxlovid	Nirmatrelvir/Ritonavir	14	14
Arexvy	Rsvpref3 Antigen/As01e/Pf	13	13
Chlorthalidone	Chlorthalidone	13	suppressed
Hydralazine Hcl	Hydralazine Hcl	13	suppressed
Meclizine Hcl	Meclizine Hcl	13	suppressed
Baclofen	Baclofen	12	suppressed
Digoxin	Digoxin	12	suppressed
Novolin R Flexpen	Insulin Regular, Human	12	suppressed
Xarelto	Rivaroxaban	12	suppressed
Advair Diskus	Fluticasone Propion/Salmeterol	11	suppressed
Aripiprazole	Aripiprazole	11	suppressed
Bumetanide	Bumetanide	11	suppressed
Combivent Respimat	Ipratropium/Albuterol Sulfate	11	suppressed
Insulin Lispro Kwikpen U-100	Insulin Lispro	11	suppressed
Lamotrigine	Lamotrigine	11	suppressed
Lansoprazole	Lansoprazole	11	suppressed
Metoclopramide Hcl	Metoclopramide Hcl	11	suppressed
Propranolol Hcl	Propranolol Hcl	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error